These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1802583)

  • 1. Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months.
    Mehta RL; McDonald BR; Ward DM
    Contrib Nephrol; 1991; 93():210-4. PubMed ID: 1802583
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients.
    Mehta RL; McDonald BR; Aguilar MM; Ward DM
    Kidney Int; 1990 Nov; 38(5):976-81. PubMed ID: 2266683
    [No Abstract]   [Full Text] [Related]  

  • 3. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
    Wu MY; Hsu YH; Bai CH; Lin YF; Wu CH; Tam KW
    Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in continuous renal replacement therapy: citrate anticoagulated continuous arteriovenous hemodialysis.
    Ashton DN; Mehta RL; Ward DM; McDonald BR; Aguilar MM
    ANNA J; 1991 Jun; 18(3):263-7, 329. PubMed ID: 2064452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation for renal replacement therapy: different methods to improve safety.
    Oudemans-van Straaten HM; Fiaccadori E; Baldwin I
    Contrib Nephrol; 2010; 165():251-262. PubMed ID: 20427976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin-induced thrombocytopenia and hemofiltration: regional anticoagulation with sodium citrate].
    Künstle T; Maulhardt S; Grünberger M; Rothe KF
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Feb; 35(2):115-8. PubMed ID: 10719608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia.
    Lehner GF; Schöpf M; Harler U; Pechlaner C; Joannidis M
    Blood Purif; 2014; 38(2):127-30. PubMed ID: 25412655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation.
    Margraf A; Liu C; Küllmar M; Meersch M; Rossaint J; Zarbock A
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate anticoagulation in the ICU: the Leeds experience.
    Trumper C
    Br J Nurs; 2016 Sep; 25(16):902-6. PubMed ID: 27615524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
    Trials; 2014 Nov; 15():449. PubMed ID: 25409678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White clot syndrome and continuous arteriovenous haemofiltration.
    Shelly MP; Majer RV; Perkins C; Pierce T; Nielsen MS
    Intensive Care Med; 1990; 16(5):334-5. PubMed ID: 2212262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW; Foringer JR
    Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in continuous renal replacement therapy: citrate anticoagulation update.
    Tolwani A; Wille KM
    Blood Purif; 2012; 34(2):88-93. PubMed ID: 23095407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: All Citrates Are Not Created Equal!
    Jacobs R; Honore PM; Hendrickx I; Spapen HD
    Blood Purif; 2016; 42(3):219-20. PubMed ID: 27529346
    [No Abstract]   [Full Text] [Related]  

  • 18. A case review: anticoagulation in hemodialysis patients with heparin-induced thrombocytopenia.
    Chuang P; Parikh C; Reilly RF
    Am J Nephrol; 2001; 21(3):226-31. PubMed ID: 11423693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrate anticoagulation during in vivo simulation of slow hemofiltration.
    Ahmad S; Yeo KT; Jensen WM; Landicho D; Gregory B; Moritz JL; Kenny M
    Blood Purif; 1990; 8(4):177-82. PubMed ID: 2085425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of regional citrate hemodialysis in acute renal failure.
    Lohr JW; Slusher S; Diederich D
    Am J Kidney Dis; 1989 Feb; 13(2):104-7. PubMed ID: 2916565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.